Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa

Authors:

Abstract
We report the yield of targeted universal tuberculosis (TB) testing of clinic attendees in high-risk groups. Clinic attendees in primary-healthcare facilities in South-Africa classified as high risk for TB due to the presence of one of the following risk factors: HIV-positive; contact of a patient with TB in the past year; and those with TB in the last two years underwent sputum testing for pulmonary TB. A single sample was collected for Xpert-Ultra (‘Xpert’) and culture. We report proportion positive for Mycobacterium tuberculosis. Data were analysed descriptively (counts, proportions and medians with interquartile range). The unadjusted clinical and demographic factors’ relative risk of TB detected by culture or Xpert were calculated and concordance between Xpert and culture is described. A total of 30513 participants had a TB test result. Median age was 39, and 11553 (38%) were men. The majority (n = 21734, 71%) had HIV infection, 12492 (41%) reported close contact with a TB patient, and 1573 (5%) reported prior TB. Overall, 8.3% were positive for M. tuberculosis by culture and/or Xpert, compared to 6.0% with trace-positive results excluded. In asymptomatic participants the yield was 6.7% and 10.1% in symptomatic participants (with trace-positives excluded). Only 10% of trace-positive results were culture-positive. We found 55% of clinic attendees with a sputum result positive for M. tuberculosis did not have a positive TB symptom screen. A high proportion of clinic attendees with specific risk factors (HIV; close TB contact; history of TB) test positive for M. tuberculosis when universal testing is implemented.
Funding Information
  • Bill & Melinda Gates Foundation
  • National Department of Health
  • City

This publication has 43 references indexed in Scilit: